Hims & Hers Health, Inc. (NYSE: HIMS) is a telehealth and consumer wellness company that became publicly traded through a merger with Oaktree Acquisition Corp., a blank-check company sponsored by affiliates of Oaktree Capital Management, L.P. The SPAC completed its initial public offering in 2020, and the business combination closed in January 2021, listing HIMS on the New York Stock Exchange. Operating in the direct-to-consumer telehealth sector, the company offers prescription and over-the-counter treatments spanning sexual health, hair care, dermatology, and mental wellness. The company filed an 8-K current report with the SEC on August 10, 2026, under accession number 0001773751-26-000161. Visit SpacDesk and sign up for full data, filings history, and analytics on HIMS and hundreds of other SPAC-originated companies.